203 related articles for article (PubMed ID: 29705849)
1. Application of Chemogenetics and Optogenetics to Dissect Brain-Immune Interactions.
Korin B; Rolls A
Methods Mol Biol; 2018; 1781():195-208. PubMed ID: 29705849
[TBL] [Abstract][Full Text] [Related]
2. Studying brain-regulation of immunity with optogenetics and chemogenetics; A new experimental platform.
Ben-Shaanan T; Schiller M; Rolls A
Brain Behav Immun; 2017 Oct; 65():1-8. PubMed ID: 27890661
[TBL] [Abstract][Full Text] [Related]
3. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools.
Boehm MA; Bonaventura J; Gomez JL; Solís O; Stein EA; Bradberry CW; Michaelides M
Pharmacol Biochem Behav; 2021 May; 204():173147. PubMed ID: 33549570
[TBL] [Abstract][Full Text] [Related]
4. Optogenetics and pharmacogenetics: principles and applications.
Jiang J; Cui H; Rahmouni K
Am J Physiol Regul Integr Comp Physiol; 2017 Dec; 313(6):R633-R645. PubMed ID: 28794102
[TBL] [Abstract][Full Text] [Related]
5. Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.
Galvan A; Caiola MJ; Albaugh DL
J Neural Transm (Vienna); 2018 Mar; 125(3):547-563. PubMed ID: 28238201
[TBL] [Abstract][Full Text] [Related]
6. Optogenetics and Chemogenetics.
Vlasov K; Van Dort CJ; Solt K
Methods Enzymol; 2018; 603():181-196. PubMed ID: 29673525
[TBL] [Abstract][Full Text] [Related]
7. Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression.
Muir J; Lopez J; Bagot RC
Neuropsychopharmacology; 2019 May; 44(6):1013-1026. PubMed ID: 30555161
[TBL] [Abstract][Full Text] [Related]
8. Optogenetics to Interrogate Neuron-Glia Interactions in Pups and Adults.
Habermacher C; Manot-Saillet B; Ortolani D; Ortiz FC; Angulo MC
Methods Mol Biol; 2021; 2191():135-149. PubMed ID: 32865743
[TBL] [Abstract][Full Text] [Related]
9. Optogenetic and chemogenetic manipulation of seizure threshold in mice.
Kravchenko JA; Goldberg EM; Mattis J
STAR Protoc; 2023 Mar; 4(1):102019. PubMed ID: 36640370
[TBL] [Abstract][Full Text] [Related]
10. Optogenetic and chemogenetic therapies for epilepsy.
Walker MC; Kullmann DM
Neuropharmacology; 2020 May; 168():107751. PubMed ID: 31494141
[TBL] [Abstract][Full Text] [Related]
11. Light Up the Brain: The Application of Optogenetics in Cell-Type Specific Dissection of Mouse Brain Circuits.
Lee C; Lavoie A; Liu J; Chen SX; Liu BH
Front Neural Circuits; 2020; 14():18. PubMed ID: 32390806
[TBL] [Abstract][Full Text] [Related]
12. Chemogenetic and Optogenetic Manipulations of Microglia in Chronic Pain.
Parusel S; Yi MH; Hunt CL; Wu LJ
Neurosci Bull; 2023 Mar; 39(3):368-378. PubMed ID: 35976535
[TBL] [Abstract][Full Text] [Related]
13. Considerations for the use of virally delivered genetic tools for in-vivo circuit analysis and behavior in mutant mice: a practical guide to optogenetics.
Zelena D; Demeter K; Haller J; Balázsfi D
Behav Pharmacol; 2017 Dec; 28(8):598-609. PubMed ID: 29099403
[TBL] [Abstract][Full Text] [Related]
14. The Use of DREADDs to Deconstruct Behavior.
Whissell PD; Tohyama S; Martin LJ
Front Genet; 2016; 7():70. PubMed ID: 27242888
[TBL] [Abstract][Full Text] [Related]
15. Silencing Neurons: Tools, Applications, and Experimental Constraints.
Wiegert JS; Mahn M; Prigge M; Printz Y; Yizhar O
Neuron; 2017 Aug; 95(3):504-529. PubMed ID: 28772120
[TBL] [Abstract][Full Text] [Related]
16. Optogenetics in Drosophila Neuroscience.
Riemensperger T; Kittel RJ; Fiala A
Methods Mol Biol; 2016; 1408():167-75. PubMed ID: 26965122
[TBL] [Abstract][Full Text] [Related]
17. Combined Optogenetic and Chemogenetic Control of Neurons.
Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared deep brain stimulation via upconversion nanoparticle-mediated optogenetics.
Chen S; Weitemier AZ; Zeng X; He L; Wang X; Tao Y; Huang AJY; Hashimotodani Y; Kano M; Iwasaki H; Parajuli LK; Okabe S; Teh DBL; All AH; Tsutsui-Kimura I; Tanaka KF; Liu X; McHugh TJ
Science; 2018 Feb; 359(6376):679-684. PubMed ID: 29439241
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and Optogenetics.
Lee GH; Kim SS
Mediators Inflamm; 2016; 2016():5808215. PubMed ID: 26884648
[TBL] [Abstract][Full Text] [Related]
20. Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice.
Berg L; Gerdey J; Masseck OA
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
